Observational Study to Evaluate Long-Term Outcome in Hip Hemiarthroplasty
A Post-market Clinical Follow-up (PMCF) Study to Evaluate Clinical, Radiographic and Patient Reported Outcomes Following a Hip Hemiarthroplasty Surgery Using Corin Devices
1 other identifier
observational
368
1 country
4
Brief Summary
This PMCF study is designed to collect safety and efficacy data on hip hemiarthroplasty surgeries with Corin BiPolar-i shell and the Oceane+ or Meije Duo femoral stem up to 10 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2023
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 6, 2023
CompletedFirst Posted
Study publicly available on registry
January 17, 2023
CompletedStudy Start
First participant enrolled
June 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2035
March 18, 2026
March 1, 2026
5.2 years
January 6, 2023
March 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of safety of the study devices at 2 years after a hip hemiarthroplasty surgery.
Intraoperative and postoperative adverse events (hip, device or procedure related) will be recorded.
2 years
Secondary Outcomes (6)
Evaluation of mid-term and long-term safety of the study devices up to 10 years.
10 years
Evaluation of study devices performance and benefit through patient's mobility from baseline to 10-year FU.
10 years
Evaluation of study devices performance and benefit through patient's quality of life from baseline to 10-year FU.
10 years
Radiographic analysis to detect acetabular erosion
2 years
Radiographic analysis to detect femoral stem stability
2 years
- +1 more secondary outcomes
Study Arms (1)
Hip hemiarthroplasty with BiPolar i and cemented stems (Meije or Oceane+)
Subjects clinically suitable for a hip hemiarthroplasty surgery with Corin hip devices
Interventions
Hip hemiarthroplasty is a surgical procedure that involves replacing half of the hip joint
Eligibility Criteria
Subjects clinically suitable for a hip hemiarthroplasty surgery with Corin hip devices based on physical examination, medical history and diagnosis such as: non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis in which the acetabulum does not require replacement, treatment of non-union, femoral neck and trochanteric fractures of the proximal femur, revision of failed partial hip replacements in which the acetabulum does not require replacement.
You may qualify if:
- Both genders.
- Adult subjects.
- Subjects clinically suitable for a hip hemiarthroplasty surgery with Corin hip devices based on physical examination, medical history and diagnosis such as: non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis in which the acetabulum does not require replacement, treatment of non-union, femoral neck and trochanteric fractures of the proximal femur, revision of failed partial hip replacements in which the acetabulum does not require replacement.
- The subject is willing to comply with the required follow-up visits as per protocol.
- The subject, or a designated trusted person in case the subject is unable to do, has signed a Patient Informed Consent Form (PICF), specific to this study, and approved by the local EC.
You may not qualify if:
- Subjects with active infection or sepsis or osteomyelitis.
- Subjects with unsuitable or insufficient bone support preventing proper fixation of the prosthesis.
- Subject with marked bone loss or bone absorption.
- Subject with metabolic disorders which may impair bone formation or bone quality.
- Subjects under guardianship.
- Subjects under jusicial protection
- Subjects in the opinion of the Investigator/ investigative team who will be unable to comply with study procedures (Examples: recent psychotic or mania disorders, alcohol, drug or substance abusers) and/or those unable for any medical or other reason to comply with study procedures/visits.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Corinlead
Study Sites (4)
Ch Amboise
Amboise, France, 37403, France
Polyclinique Henin Beaumont
Hénin-Beaumont, 62110, France
Hopital Saint Joseph
Paris, 75014, France
Hopital Diaconesses Croix Saint Simon
Paris, 75020, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Christophe HULET, MD, PhD
University Hospital, Caen
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 6, 2023
First Posted
January 17, 2023
Study Start
June 29, 2023
Primary Completion (Estimated)
September 1, 2028
Study Completion (Estimated)
September 1, 2035
Last Updated
March 18, 2026
Record last verified: 2026-03